Medtronic Plc

NYSE:MDT   3:59:57 PM EDT
128.77
-1.25 (-0.96%)
4:00:01 PM EDT: $128.75 -0.02 (-0.02%)
Positive Earnings Pre-Announcement

Medtronic Reports Q1 EPS Of $0.56

Published: 08/24/2021 11:35 GMT
Medtronic Plc (MDT) - Medtronic Reports First Quarter Fiscal 2022 Financial Results.
Q1 Non-GAAP Earnings per Share $1.41.
Q1 GAAP Earnings per Share $0.56.
Q1 Earnings per Share Estimate $1.32 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Revenue of $8.0 Billion Increased 23% Reported and 19% Organic.
Reiterates FY22 Revenue Guidance; Raises Lower End of FY22 EPS Guidance by 5 Cents.
Q1 Results Reflect a Strong Recovery From Impact of Covid-19 Pandemic on Elective Procedures That Company Experienced in 2020.
Q1 U.S. Revenue of $4.101 Billion Represented 51% of Company Revenue and Increased 22%.
Cardiovascular Q1 Revenue of $2.890 Billion Increased 19% As Reported and 15% Organic.
Cardiac Rhythm & Heart Failure Q1 Revenue of $1.483 Billion Increased 19% As Reported and 15% Organic.
If Current Exchange Rates Hold, Revenue Growth in Fiscal Year 2022 Would Be Positively Affected by Approximately $100 to $200 Million.
Increased Its Fiscal Year 2022 Diluted Non-GAAP EPS Guidance From Prior Range of $5.60 to $5.75 to New Range of $5.65 to $5.75.
Medical Surgical First Quarter Revenue of $2.322 Billion Increased 29% As Reported and 25% Organic.
Q1 Revenue View $7.87 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $5.69, Revenue View $33.22 Billion -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $7.98 Billion
Adjusted EPS is expected to be $1.29

Next Quarter Revenue Guidance is expected to be $8.25 Billion
Next Quarter EPS Guidance is expected to be $1.41

More details on our Analysts Page.